Research Compound
GLP3-R
Researchers are particularly interested in GLP3-R (Retatrutide) because of its unique triple-agonist mechanism, which combines:
- GLP-1 receptor activity associated with appetite and satiety signaling
- GIP receptor activity linked to metabolic regulation and glucose response
- Glucagon receptor activity associated with increased energy expenditure and fat metabolism research
Early investigational data has also suggested:
- Significant reductions in visceral fat and waist measurements
- Continued weight-loss trends beyond 48 weeks without early plateauing in some studies
- Potential support for metabolic flexibility and body recomposition research
- Promising liver-fat reduction data in metabolic dysfunction studies
GLP3-R is manufactured to strict research-grade standards with an emphasis on purity, consistency, and laboratory integrity for advanced peptide and metabolic research applications.
Key Features
- Triple-agonist research peptide formulation
- Research-grade purity and quality standards
- Studied for metabolic and body composition research
- Advanced peptide stability and consistency
- Intended strictly for laboratory and investigational use
Disclaimer:
GLP3-R is intended for laboratory research purposes only. This product is not approved by the FDA for human consumption, diagnosis, treatment, cure, or prevention of any disease. Not for medical or veterinary use.
Research application details for GLP3-R. For specific protocol information, please refer to current peer-reviewed literature.
- Research-grade purity, independently verified
- Certificate of Analysis included with every order
- GLP3-R — Default Title
- Intended strictly for laboratory and research use only
This product is intended for laboratory research purposes only. This product is not approved by the FDA for human consumption, diagnosis, treatment, cure, or prevention of any disease. Not for medical or veterinary use.